Bionano Genomics Inc at Panel Testing and Susceptibility -- Clearing: Testing and Susceptibility -- Clearing the Air Transcript
Okay. Welcome back, everybody, to our second panel. We just heard from some really, really interesting companies on the cell therapy side of COVID. We want to turn our attention now. So it's on so many people's minds these days, especially with everything reopening, enough testing. We need it. We really don't seem to have enough of it, but that is really changing, much of which you're going to hear from some of the companies on this panel today. So there's been a tremendous amount of availability and accessibility that these companies have contributed to. We're also learning a tremendous amount about susceptibility at the genomic level, we're going to hear a little bit about that. But there still seems to be a lot of confusion when you just talk to random people about where testing is in the space, then we're going to try to clear that air with this panel. So with that, I want to introduce our panelists, our presenting companies, who will reach out, give you a short presentation before we talk about everything that's going on in testing.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |